The Kindness Coalition: Transforming Health Care Through Compassion

The Kindness Coalition: Transforming Health Care Through Compassion

#Communities

Prerak Juthani, MD, and Amity Eliaz, MD, at a Kindness Coalition event, promoting compassionate care at Stanford Hospital’s ‘Kindness Kickback’

It was 3 a.m. on a brisk mid-November night. Flu season was in full swing, and Stanford Hospital had been at full capacity for two weeks straight. Inside the team room, internal medicine residents Prerak Juthani, MD, and Amity Eliaz, MD, finally found a fleeting moment of respite. The room, dimly lit and filled with the hum of medical equipment, was their temporary sanctuary. Both physically and emotionally drained, they sank into their chairs, exchanging sighs of relief.  

The two residents began to recount the past several nights. They spoke of responding to urgent messages, racing between units, and coordinating ICU transfers. Amid the chaos, a pattern emerged in their stories. It was the small acts of kindness and moments of clear, respectful communication that stood out. These simple gestures had the remarkable power to transform challenges – and even moments of crisis – into opportunities for connection and resilience. 

Eliaz and Juthani were onto something. In fact, they had stumbled upon an issue that was endemic to hospital systems nationwide. A study published in The British Medical Journal found that communication failures are a common cause of inadvertent patient harm. The study emphasized the importance of fostering an environment where individuals could speak up, express concerns, and share common “critical language” to alert team members to unsafe situations.

As Juthani and Eliaz sipped their lukewarm coffee, an idea began to take shape in their minds. What if they could create an initiative to foster a culture of kindness throughout the hospital?

And so, in the middle of the night, The Kindness Coalition (TKC) was born. Juthani and Eliaz’s vision was clear: to create a hospital culture where kindness was not just an occasional gesture but a fundamental practice, enhancing both patient outcomes and team morale.

The Kindness Coalition team at Stanford Hospital’s ‘Kindness Kickback,’ gathering to celebrate the power of compassion and support in health care

“Kindness builds community. It reduces isolation, decreases burnout, and even cultivates resilience.”

– Amity Eliaz, MD

Kindness Kickbacks

In the bustling break room at Stanford Hospital, the latest event hosted by TKC gathers momentum. Over 50 healthcare professionals from diverse fields – doctors, nurses, social workers, technicians, and more – convene not just for the provided boba and cookies, but for a cause much more vital: fostering kindness within the stress-laden corridors of the hospital.

This event is called a “Kindness Kickback.” It’s a monthly initiative organized by TKC that allows healthcare workers to build relationships, share communication strategies, and unwind together. 

As the event unfolds, people stream in and out of the break room. Some arrive with heavy expressions, visibly weighed down by the stressors that lie just beyond the break-room door. However, after a few minutes, their energy visibly shifts. Expressions soften, the room rings with laughter. 

“Kindness builds community,” shares Eliaz. “It reduces isolation, decreases burnout, and even cultivates resilience.”  

These monthly events are one of the many core strategies employed by TKC. Another strategy is the “Kindness Recognition Form,” which allows staff to acknowledge and celebrate the kind acts of their peers. Whenever a form is submitted, both the recognized individual and their supervisor receive an email, reinforcing the value of kindness and acknowledging its positive impact.

Additionally, TKC distributes symbolic pins for name tags, designed to remind and encourage staff to engage in kind interactions throughout their day.

"

Exploring the Science Behind Kindness

Kindness, while seemingly simple, can be difficult to define. It manifests in myriad ways and varies across different perspectives. One study simply characterizes kindness as “an action that benefits another, as perceived by the recipient of the kind action.”

Eliaz and Juthani encourage the event attendees to define kindness themselves. A large bulletin board reads, “What does kindness mean to you?” The attendees write their answers on colorful Post-it notes, with responses ranging from “Smiling and saying hello to each other in the hallways” to “Helping one another without expectations in return.”

At the Kindness Kickback, one healthcare provider has found her way into the break room. She’s totally new to TKC, but she’s heard the rumor of free boba and is drawn in. She asks about TKC’s mission, and her eyes widen in pleasant surprise. “Sometimes all it takes is for me to see a warm smile to turn my entire day around. I am so glad to know this mission exists, and I will be spreading the word wide and far.” 

Echoing this sentiment, Chief Resident Hayley Galitzer, MD, an active participant and leader in TKC, adds, “In the high-pressure world of health care, a simple act of kindness can profoundly impact someone’s day. An act of kindness reminds us that our greatest impact comes from our ability to understand and care for one another.”

Research shows that kind behavior in health care is not just about being nice; it involves deliberate, prosocial acts that benefit both the giver and the receiver, ultimately enhancing the overall workplace atmosphere. However, in high-stress situations, such as night shifts or emergencies, kind communication often diminishes.

TKC is now developing a comprehensive tool kit aimed at guiding kind communication in critical healthcare situations. This tool kit is based on evidence-based principles, providing practical advice and strategies to help healthcare workers communicate more effectively and compassionately.

Personal reflections from attendees on what kindness means to them, shared during the Kindness Kickback event at Stanford Hospital

"

Expanding Reach and Impact

TKC has rapidly gained momentum, drawing more than 100 attendees from diverse healthcare professions to each event. 

“We see TKC not just as an initiative but as a movement,” says Poonam Hosamani, MD, one of the faculty sponsors. “One that we hope will inspire other institutions to weave kindness into their fabric of operations.”

As TKC plans to expand, the hope is to set a new standard for healthcare environments, not just at Stanford but nationwide. 

In advancing medical excellence and innovation, The Kindness Coalition highlights a crucial frontier: integrating compassion in health care. TKC serves as a model for healthcare systems globally, demonstrating that the future of medicine focuses not only on healing patients but also on strengthening the well-being and camaraderie of the healthcare teams that deliver care. 

Pioneering New Frontiers: Tri-Valley Hospital’s Family Medicine Residency Tackles Doctor Shortage

Pioneering New Frontiers: Tri-Valley Hospital’s Family Medicine Residency Tackles Doctor Shortage

#Communities

Minjoung Go, MD, a trailblazer at Stanford Health Care Tri-Valley, has transformed the hospital into an academic powerhouse, launching a new Family Medicine Residency to address the primary care shortage.

As one of the first faculty members at Stanford Health Care Tri-Valley in 2015, Minjoung Go, MD, clinical associate professor, never imagined she would lead the hospital’s metamorphosis from a community hospital into an educational powerhouse. 

She spent nine years orchestrating complex internal infrastructures to expand Stanford’s top-notch clinical, educational, and research footprint into the East Bay. The crowning achievement so far is the Family Medicine Residency Program, which has the dual mission of training the next generation of physicians and addressing the Tri-Valley community’s urgent need for primary care doctors. 

The Family Medicine Residency Program integrates academic medicine and community-centric health services to prepare future family physicians for an advancing frontier in medicine that seeks to balance specialized healthcare delivery with community care.

“This hospital has deep roots in the community, and that will always be at its core,” Go says. “We are bringing Stanford’s resources here to grow together with the community.”

Stanford Health Care Tri-Valley (then named Valley Memorial Hospital) was originally established in 1961 to serve the communities of Pleasanton, Livermore, and Dublin – collectively known as the Tri-Valley area. In 2015, Stanford Health Care acquired the hospital system to transform it into a leading medical, academic, and research health system in line with Stanford’s reputation for rigor and quality to meet the healthcare needs of these growing suburban communities.

Under Go’s leadership, Tri-Valley Hospital received accreditation from the Accreditation Council for Graduate Medical Education, and in June 2025, eight inaugural interns will join the Family Medicine Residency Program.

Unlike Stanford’s main campus, the hospital wasn’t designed to be an educational institution.

Go, along with Kathleen Jia, MD, medical director for education, and Lijia Xie, MD, associate medical education director, had to get stakeholder buy-in, create and implement all the inner workings of a medical education system to meet requirements, and obtain accreditation for the Family Medicine Residency Program.

“Everything we’ve done is from scratch,” Go says. “We had to build the entire educational infrastructure and secure the necessary approvals, all while continuing to provide patient care.”

The program’s inclusive curriculum goes beyond the traditionally specialized medical care approach typically observed in academic health systems. It addresses local health challenges and needs, builds strong relationships with local federally qualified health centers and Stanford partners, and offers a mix of inpatient and outpatient experiences.

"

“This hospital has deep roots in the community, and that will always be at its core,” Go says. “We are bringing Stanford’s resources here to grow together with the community.”

– Minjoung Go, MD

In close collaboration with leaders from the Division of Primary Care and Population Health, Go’s team recruited the program director, developed outpatient and inpatient experiences, built relationships with community clinics, and interfaced with future educators in the Tri-Valley.

“Dr. Go has exerted extraordinary efforts that have advanced the missions of Stanford University and Stanford Health Care,” says Tri-Valley’s chief medical officer, David Svec, MD.

As Tri-Valley expanded, Go zeroed in on the lack of family doctors in the area by turning her attention to building out the much-anticipated Family Medicine Residency Program. 

From its community roots to an academic hub, Stanford Health Care Tri-Valley has evolved into a center of clinical, educational, and research excellence, launching a Family Medicine Residency Program to train the next generation of primary care doctors.

In theory, it sounds simple: Residents already at the Stanford campus can quickly hop across the Bay to Tri-Valley to see patients. But it turned out to be much more complex. 

“It doesn’t work that way. We had to go through all the right compliances and regulatory pieces – none of which were present,” Go says. “We had to learn and figure out what the process was and then implement it and get the right approval from the medical staff and the hospital.” 

Tri-Valley needed to become a qualified sponsoring institution to provide graduate medical education, and then Go and her team needed to design and build an entire residency curriculum and hire the faculty.

None of that would have been possible without Go’s extensive efforts to shift the culture of Tri-Valley to focus more on the academic mission of education and research, says Jia.

“She was thorough and meticulous, with a vision of the goal but also focused on the details and made sure things were done right from the beginning steps,” Jia says. “This really speaks to her drive, vision, and dedication to building the frontiers of academic education at Tri-Valley.”

The hard work has been worth it.

“What makes everyone so excited and supportive about this initiative is that we are driven by passions and beliefs that family doctors will make a big difference and impact in this community,” Go says.

Price Defines the Generic Drug Market

Price Defines the Generic Drug Market

#Interventions

Kevin Schulman, MD, MBA, is a Stanford health economist dedicated to revealing the downside of the generic drug marketplace – one that has saved consumers billions of dollars in drug costs annually but that is still “deeply flawed.”

A shortage of cisplatin, a key cancer chemotherapy agent, resulted in a crisis for Stanford Medicine and many other healthcare systems in 2023. A Food and Drug Administration (FDA) inspection had found severe quality problems at one of the largest foreign manufacturers of this generic drug.

Guided by principles of ethics, potential impact on prognosis, and clinical judgment, a multidisciplinary committee helped determine the allocation of cisplatin to patients on a case-by-case basis. At that time, Neera Ahuja, MD, was medical director of pharmacy. She recalls that “all the patients at Stanford received the care they needed, and there were no negative impacts to clinical care.” Ahuja is currently associate chief medical officer, Inpatient Care Services.

Drug Detective Seeks Answers

While the Stanford bioethics committee was developing criteria for rationing the available supply of cisplatin for its cancer patients, Kevin Schulman, MD, MBA, was working to explain the economic factors that resulted in this crisis. Schulman is a health economist and professor of medicine at Stanford and is interim division co-chief for the Division of Hospital Medicine.

“There is a lot of focus in this country on the high cost of branded drugs,” says Schulman, whose research on generic drugs is carried out within the Stanford Department of Medicine’s Clinical Excellence Research Center (CERC). “However, 90% of all prescriptions are written for generic versions of formerly branded products – drugs whose patent protection has expired.” This process has saved billions of dollars for consumers. At the same time, the generic drug marketplace has become deeply flawed, according to Schulman.

"

“Generic drug shortages and generic drug quality are solvable problems. We need a new economic model that incorporates both price and quality into its infrastructure to deliver more for our patients.”

– Kevin Schulman, MD, MBA

The Generic Drug Market’s Sole Platform

In the branded drug market, manufacturers have the power to set prices. By contrast, in the generic market, distributors and other drug purchasers have consolidated into a limited number of purchasing coalitions that have the power to drive down prices. In fact, they can push prices so low that many generic drug manufacturers leave the market because they can no longer make a profit. And since the generic drug market is entirely based on price, there is no incentive for manufacturers to invest in quality – both product quality (its safety and efficacy) and supply chain quality (the assurance that high-quality products are always available).

“Unlike other industries,” notes Schulman, “the generic drug market is solely based on price. Drug distributors and purchasing groups claim the FDA oversees drug quality, but the FDA is struggling to police every transaction in a global market.”

Schulman has worked with Intermountain Healthcare (a large healthcare system based in Salt Lake City) to create Civica Rx, a not-for-profit generic drug company designed to change the incentives in the generic market for purchasers and health systems. Schulman is an unpaid member of the Scientific Advisory Board for Civica Rx, which offers stable, long-term procurement contracts that supply up to half of the needs for generic drugs for member health systems.

This model starts with a slightly higher but more stable price for generic drugs. Over time, the Civica model has resulted in reduced costs for generic drugs by eliminating the shortages and price swings that are typical of the generic market.

Product Recalls and Shortages

Schulman believes we can largely eliminate the challenge of generic drug quality and the larger issue of shortages if we force the purchasers in the market to consider both price and quality in contracting with generic drug manufacturers. “We have sophisticated purchasers buying millions of units of product, but not asking anything about product quality. I can’t imagine any other market in the world that functions this way.”

He argues that the FDA always lags behind purchasers’ procurement decisions. During the COVID-19 pandemic, the FDA fell way behind in its inspections. The Government Accountability Office reported that at the end of 2022, the FDA had not inspected 61% of critical overseas sites in five years. “And an FDA inspection merely reviews quality documents maintained by the manufacturer. They do not routinely test the medications themselves for quality,” Schulman says. In fact, he recently detected carcinogens in some generic drugs, even after FDA recalls, likely resulting from low-quality manufacturing processes.

“It’s been both exciting and frustrating to examine this market, which is a critical part of our healthcare system that has been largely neglected by the research community,” he says. “Generic drug shortages and generic drug quality are solvable problems. We need a new economic model that incorporates both price and quality into its infrastructure to deliver more for our patients.”

New Division to House Research Centers

In September 2023, a new administrative division was created for the Stanford Department of Medicine. CERC and five other research entities are now organized under one umbrella, called the Division for Research and Education in Academic Medicine (DREAM). “This is an exciting moment for the Department of Medicine. I am confident that DREAM will contribute great value to the department and to each of the programs and centers within this new division,” says Interim Chair of the Department of Medicine Bonnie Maldonado, MD. The six entities in this new division are as follows:

  • Program for Bedside Medicine
  • Center for Asian Health Research and Education
  • Center for Digital Health
  • Clinical Excellence Research Center
  • Translational Research and Applied Medicine Center
  • Translational Applications Service Center

Mentorship Reimagined: The MODEL Program’s Impact on Faculty Development at Stanford

Mentorship Reimagined: The MODEL Program’s Impact on Faculty Development at Stanford

#Communities

With an inaugural cohort of seven faculty mentors and 87 mentees, the MODEL program has already had significant impacts on faculty across department divisions and organizations.

“One of the best things that has happened to me as a result of the MODEL program is to make connections with other early-career women faculty,” says Clinical Assistant Professor of Cardiovascular Medicine and MODEL mentee Jennifer Woo, MD. “I was waiting to give my talk at a major international scientific meeting. I could not feel my fingers, I was so nervous.” 

Woo texted two fellow MODEL mentees, who talked her through her nerves. They told her to write down the names of several people and imagine she was giving the talk to them. “It worked!” Woo says. “I won the Young Investigator Award!” 

MODEL program leaders, alongside the inaugural cohort of participating faculty mentors and mentees, have been hard at work since the program launched in January 2024. MODEL, shorthand for Mentorship | Opportunity | Development | Empathy | Leadership, champions a dynamic new mentoring culture across the Department of Medicine. 

With an inaugural cohort of seven faculty mentors, called MODEL leads, and 87 mentees, the program has already had significant impacts on faculty across department divisions and organizations. 

“The MODEL program helps relieve the burden of finding (and providing) mentorship, because it broadens the definition of mentorship beyond the classic one-to-one ‘advisor-advisee’ relationship most of us think of,” says the department’s senior vice chair for clinical affairs, Ann Weinacker, MD. MODEL, she says, “allows experienced faculty to share their knowledge and experience with groups of early-career faculty in a casual and relaxed atmosphere that promotes open dialogue.”

The group format also provides opportunities for networking with colleagues and other more senior faculty and for developing relationships that are mutually beneficial, including classic mentoring and sponsorship relationships that, according to Weinacker, often seem elusive.

"

“There’s something magical about regular group meetings, and MODEL is proof. To me, the mutual support, the sense of community, and connection is as precious as the mentorship. Why else would its members carve out time they don’t have to be there?”

– Abraham Verghese, MD

Trained, Dedicated Mentors

The MODEL leads’ commitment to this initiative is as impressive as it is inspiring. In addition to the myriad personal and professional demands on clinical faculty, MODEL leads undergo three months of formal training with the Teaching and Mentoring Academy in the School of Medicine. The curriculum covers, among other topics, mentorship principles, communication strategies, and teaching methodologies. Leads also engage in continuing learning from the medical school’s Office of Academic Affairs, as well as the department’s Diversity, Equity, and Inclusion Council; Team Science initiatives; and Making SPACE program.

MODEL leads serve their term as dedicated faculty to help facilitate promotion and advancement of their colleagues, train others to develop strong mentoring relationships, and provide ongoing workshops to promote networking and mentorship. 

Behind the leads’ dedication to the program’s mission is a sense of the importance of establishing mentorship as a core cultural value in the department and converting that shared belief into regular practice across divisions. 

“Mentorship has traditionally been an expectation in academic departments, rather than an intentional investment and strategy to support the success, well-being, and belonging of our early-career faculty,” says Niraj Sehgal, MD, clinical professor of hospital medicine and senior associate dean for clinical affairs in the School of Medicine. “MODEL is such an exemplary program to achieve those goals.”

Connecting Mentees and Mentors Across Divisions and Career Stages

To achieve that common objective, MODEL mentors and mentees initiate and engage in small and large group discussions celebrating mentorship as beneficial for faculty members at all stages of their careers.

For example, “For clinician educators (CEs), the majority of our interactions with colleagues in the department are to discuss mutual patients,” says MODEL mentee and Clinical Associate Professor of Endocrinology Marilyn Tan, MD. “But MODEL provides a chance to have exchanges with colleagues across divisions, with a focus on career and work-life balance.”

“There’s something magical about regular group meetings, and MODEL is proof,” concurs Vice Chair for the Theory and Practice of Medicine Abraham Verghese, MD. “To me, the mutual support, the sense of community, and connection is as precious as the mentorship. Why else would its members carve out time they don’t have to be there?”

"

Mentorship Matters

With the first year of operation complete and planning for the next year underway, the MODEL program is very much in the hearts and minds of department participants and leaders, and many are invested in its continuing success. 

“MODEL reminds us of why we’re grateful to be at Stanford and in an environment where we’re continually finding ways to invest in ourselves and each other,” Sehgal reflects.  

Former program leader Upinder Singh, MD, shares, “We should call the story ‘a labor of love,’ since that really is what we are talking about.” Her program co-leads, Kavitha Ramchandran, MD, and Rebecca Geraldi, readily agree.

The 2024 cohort of MODEL Leads is dedicated to the importance of establishing mentorship as a core cultural value in the department and converting that shared belief into regular practice across divisions.

New Frontiers in Team Science: Empowering Patients With AI-Driven E-Consults

New Frontiers in Team Science: Empowering Patients With AI-Driven E-Consults

#Methods

From left: Olivia Jee, MD; Vijaya Parameswaran, PhD; Ron Li, MD; and Srikanth Muppidi, MD

For patients with rare diseases, the time to obtain a definite diagnosis can be months or even years. During that period, even minor communication gaps can lead to dead ends and lengthen the journey. Here is a typical scenario:

Patient A goes to see their primary care physician complaining of diffuse symptoms that have plagued them for some time. The physician suspects a neurological disorder and initiates what is known as an e-consult – a digital, physician-to-physician communication. The patient’s symptoms are described in medical shorthand, including numerous acronyms and technical terms. The consulted neurologist suggests a series of tests, which are ordered and performed in the following days and weeks, all with negative or inconclusive results. 

The primary care physician refers the patient for an in-person visit to the neurologist, who is not available for some months. When that date finally arrives, the neurologist consults the notes received and discusses them with the patient. The patient clarifies one particular symptom as well as its timing: “No, that is incorrect. Here’s what actually happened…”

That clarification serves as a clue, and after a careful examination and more questions, the neurologist confirms the diagnosis of a rare disease, at which point the patient is put on appropriate medication. The time from initial visit to treatment: several months, during which the patient’s condition has worsened.

Patient A knew how to access the physician’s notes and the response from the neurologist. But the medical terminology and the acronyms used obscured the fact that there was a miscommunication about one crucial symptom and its timing, which then led to a series of mistaken assumptions. 

What if an AI tool could serve as an interpreter to translate physicians’ notes into lay language? What if patients could easily access this translation and directly respond with corrections or additional details? 

These questions will be explored in a new pilot study at Stanford. In an example of true team science, the project brings together professionals from different fields. Primary care physicians, neurologists, and experts in AI tools for medicine will investigate how patients communicate with their care team and how they could be active participants when their primary care physician consults a specialist.

“Timely communication is essential in healthcare delivery. We are exploring whether the integration of large language models can augment human clinical care by improving the efficiency and effectiveness of patient communication,” says Vijaya Parameswaran, PhD, a social scientist in the Division of Cardiology and co-principal investigator of the study. Large language models, she explains, are the foundation for chatbots like ChatGPT – computer programs that simulate and process human conversation, either written or spoken.

The research will also study how physicians consult with each other and with their patients during an e-consult to see if artificial intelligence language models can improve these interactions and information sharing.

“The time it takes the primary care physician to formulate a tight, well supported clinical question and the specialist’s time providing a clinical assessment and recommendations impact the quality and quantity of e-consults. If AI can aid to overcome these barriers, it will help us continue to grow the program and provide more efficient clinical care,” says Olivia Jee, MD, a primary care physician, clinical assistant professor of primary care and population health, and medical director of the Stanford Health Care eConsult Program.

"

“Timely communication is essential in healthcare delivery. We are exploring whether the integration of large language models can augment human clinical care by improving the efficiency and effectiveness of patient communication,” says Vijaya Parameswaran, PhD

For example, an AI language tool could be used by a specialist to quickly scan and condense what is often hundreds of pages of history and data that patients with rare diseases typically bring to a consultation. The most brilliant human minds do not have the capacity to digest thousands of pieces of information in a few minutes and come to rational conclusions. A large language model tool can serve as an “extra brain” to sift through the data, bring the most relevant facts into focus, and suggest the most likely diagnosis and possible treatments, according to Srikanth Muppidi, MD, clinical professor of neurology and neurological sciences and co-investigator in the study.

“With the increasing complexity of care and silos of knowledge, it is impossible for primary care or referring physicians to always obtain and interpret relevant clinical information. This study will help us understand how best to use AI tools to review referrals, both to reduce the time to diagnosis and to help choose the best therapy for each individual,” says Srikanth Muppidi, MD.

On the patient side, the same tools could empower them with language and technological resources that would help them communicate about their symptoms and disease history. A rare disease forces patients on a journey from primary care to specialists to subspecialists, each time having to explain the course of their condition, pointing out tests that have been administered, and describing the effects of attempted treatments. By making it easier for patients to be actively involved in the process of diagnosis and disease management, the Stanford team hopes to shorten these difficult journeys and improve outcomes for patients.

The study is a joint project of the Stanford Department of Medicine Team Science program, the Stanford Health Care Digital Healthcare Integration Team, and UCB Biopharma, the industry sponsor.

“Large language models have shown tremendous promise in improving clinical workflows by helping to summarize and translate information,” says Ron Li, MD, a clinical associate professor of medicine and medical informatics director for digital health, who is the principal investigator of the study. “The goal of this project is to explore how we can apply this capability to enable and transform care models such as e-consults while keeping patients at the center.”       

Social Scientist in Cardiovascular Medicine Vijaya Parameswaran, PhD